Apontis Pharma AG APPH:XETRA

*Data is delayed | Exchange | EUR
Last | 5:36 PM CEST
8.26quote price arrow down-0.02 (-0.24%)
Volume
5,149
52 week range
3.03 - 11.85
Loading...
  • Open8.30
  • Day High8.30
  • Day Low8.20
  • Prev Close8.28
  • 52 Week High11.85
  • 52 Week High Date05/02/23
  • 52 Week Low3.03
  • 52 Week Low Date11/09/23

Key Stats

  • Market Cap73.77M
  • Shares Out8.33M
  • 10 Day Average Volume3,671.2
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change73.89

KEY STATS

  • Open8.30
  • Day High8.30
  • Day Low8.20
  • Prev Close8.28
  • 52 Week High11.85
  • 52 Week High Date05/02/23
  • 52 Week Low3.03
  • 52 Week Low Date11/09/23
  • Market Cap73.77M
  • Shares Out8.33M
  • 10 Day Average Volume3,671.2
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change73.89

RATIOS/PROFITABILITY

  • EPS (TTM)-1.32
  • P/E (TTM)-6.26
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Apontis Pharma AG

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Apontis Pharma AG is a Germany-based manufacturer of pharmaceutical preparation. The company focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
Bruno Wohlschlegel
Chief Executive Officer, Member of the Executive Board
Address
Alfred-Nobel-Strasse 10
Monheim Am Rhein
40789
Germany